Literature DB >> 16320379

Should patients with acute myocardial infraction be transferred to a tertiary center for primary angioplasty or receive it at qualified hospitals in the community? The case for emergency transfer for primary percutaneous coronary intervention.

Ellen C Keeley1, Cindy L Grines.   

Abstract

Entities:  

Mesh:

Year:  2005        PMID: 16320379

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  5 in total

1.  The trials and tribulations of percutaneous coronary intervention in hospitals without on-site CABG surgery.

Authors:  Scott Kinlay
Journal:  JAMA       Date:  2011-12-14       Impact factor: 56.272

2.  STEMI mortality in community hospitals versus PCI-capable hospitals: results from a nationwide STEMI network programme.

Authors:  Marc J Claeys; Peter R Sinnaeve; Carl Convens; Philippe Dubois; Jean Boland; Pascal Vranckx; Sofie Gevaert; Antoine de Meester; Patrick Coussement; Herbert De Raedt; Christophe Beauloye; Marc Renard; Christiaan Vrints; Patrick Evrard
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2012-04

3.  Influences of electrocardiographic ischaemia grades and symptom duration on outcomes in patients with acute myocardial infarction treated with thrombolysis versus primary percutaneous coronary intervention: results from the DANAMI-2 trial.

Authors:  M Sejersten; Y Birnbaum; R S Ripa; C Maynard; G S Wagner; P Clemmensen
Journal:  Heart       Date:  2006-06-01       Impact factor: 5.994

Review 4.  Coronary angiography predicts improved outcome following cardiac arrest: propensity-adjusted analysis.

Authors:  Joshua C Reynolds; Clifton W Callaway; Samar R El Khoudary; Charity G Moore; René J Alvarez; Jon C Rittenberger
Journal:  J Intensive Care Med       Date:  2009-03-25       Impact factor: 3.510

5.  It's a small world after all.

Authors:  M J de Boer; H Suryapranata
Journal:  Neth Heart J       Date:  2012-06       Impact factor: 2.380

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.